Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Meijer

Showing results (251-260 of 282) with videos related to

Pageof 29
Sort By:
Leukemia|May 25, 2011
Predictive impact of allele-matching and EBMT risk score for outcome after T-cell depleted unrelated donor transplantation in poor-risk acute leukemia and myelodysplasiaT Lodewyck, M Oudshoorn, B van der Holt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 4, 2008
Association of an extracellular matrix gene cluster with breast cancer prognosis and endocrine therapy responseJozien Helleman, Maurice P H M Jansen, Kirsten Ruigrok-Ritstier, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2006
Which cyclin E prevails as prognostic marker for breast cancer? Results from a retrospective study involving 635 lymph node-negative breast cancer patientsAnieta M Sieuwerts, Maxime P Look, Marion E Meijer-van Gelder, et al.
Lancet (London, England)|February 22, 2005
Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancerYixin Wang, Jan G M Klijn, Yi Zhang, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 12, 2011
Therapeutic potential of vasopressin V2 receptor antagonist in a mouse model for autosomal dominant polycystic kidney disease: optimal timing and dosing of the drugE Meijer, R T Gansevoort, P E de Jong, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 7, 2014
High protein expression of EZH2 is related to unfavorable outcome to tamoxifen in metastatic breast cancerE A Reijm, A M Timmermans, M P Look, et al.
The European Respiratory Journal|February 13, 2010
Application of a prediction model for work-related sensitisation in bakery workersE Meijer, E Suarthana, J Rooijackers, et al.
Journal of Cancer Research and Clinical Oncology|May 11, 2015
Sensitivity to systemic therapy for metastatic breast cancer in CHEK2 1100delC mutation carriersMieke Kriege, Agnes Jager, Antoinette Hollestelle, et al.
Journal of Mathematical Neuroscience|April 9, 2015
Modeling focal epileptic activity in the Wilson-cowan model with depolarization blockHil G E Meijer, Tahra L Eissa, Bert Kiewiet, et al.
Hormones & Cancer|August 16, 2014
Elevated APOBEC3B correlates with poor outcomes for estrogen-receptor-positive breast cancersAnieta M Sieuwerts, Scooter Willis, Michael B Burns, et al.
Pageof 29

Showing results (251-260 of 282) with videos related to

Sort By:
Pageof 29
Leukemia|May 25, 2011
Predictive impact of allele-matching and EBMT risk score for outcome after T-cell depleted unrelated donor transplantation in poor-risk acute leukemia and myelodysplasiaT Lodewyck, M Oudshoorn, B van der Holt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 4, 2008
Association of an extracellular matrix gene cluster with breast cancer prognosis and endocrine therapy responseJozien Helleman, Maurice P H M Jansen, Kirsten Ruigrok-Ritstier, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2006
Which cyclin E prevails as prognostic marker for breast cancer? Results from a retrospective study involving 635 lymph node-negative breast cancer patientsAnieta M Sieuwerts, Maxime P Look, Marion E Meijer-van Gelder, et al.
Lancet (London, England)|February 22, 2005
Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancerYixin Wang, Jan G M Klijn, Yi Zhang, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 12, 2011
Therapeutic potential of vasopressin V2 receptor antagonist in a mouse model for autosomal dominant polycystic kidney disease: optimal timing and dosing of the drugE Meijer, R T Gansevoort, P E de Jong, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 7, 2014
High protein expression of EZH2 is related to unfavorable outcome to tamoxifen in metastatic breast cancerE A Reijm, A M Timmermans, M P Look, et al.
The European Respiratory Journal|February 13, 2010
Application of a prediction model for work-related sensitisation in bakery workersE Meijer, E Suarthana, J Rooijackers, et al.
Journal of Cancer Research and Clinical Oncology|May 11, 2015
Sensitivity to systemic therapy for metastatic breast cancer in CHEK2 1100delC mutation carriersMieke Kriege, Agnes Jager, Antoinette Hollestelle, et al.
Journal of Mathematical Neuroscience|April 9, 2015
Modeling focal epileptic activity in the Wilson-cowan model with depolarization blockHil G E Meijer, Tahra L Eissa, Bert Kiewiet, et al.
Hormones & Cancer|August 16, 2014
Elevated APOBEC3B correlates with poor outcomes for estrogen-receptor-positive breast cancersAnieta M Sieuwerts, Scooter Willis, Michael B Burns, et al.
Pageof 29